Reducing pathologic cytokines, including IL-17, not only ameliorates the inflammatory response of RA but also regulates osteoclastogenesis because proinflammatory cytokines promote osteoclast differentiation [13,14]. This evidence concerns the gene IL17A and rheumatoid arthritis.